Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.051 | 0.7 |
mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |